Literature DB >> 7816840

Human immunodeficiency virus (HIV) antigens: structure and serology of multivalent human mucin MUC1-HIV V3 chimeric proteins.

J D Fontenot1, J M Gatewood, S V Mariappan, C P Pau, B S Parekh, J R George, G Gupta.   

Abstract

Molecular modeling and two-dimensional NMR techniques enable us to identify structural features in the third variable region (V3) loop of the human immunodeficiency virus (HIV) surface glycoprotein gp120, in particular the principal neutralizing determinant (PND), that remain conserved despite the sequence variation. The conserved structure of the PND is a solvent-accessible protruding motif or a knob, structurally isomorphous with the immunodominant knobs in the tandem repeat protein of human mucin 1 (MUC1) (a tumor antigen for breast, pancreatic, and ovarian cancer). We have replaced the mucin antigenic knobs by the PND knobs of the HIV MN isolate in a set of chimeric human MUC1/HIV V3 antigens. This produced multivalent HIV antigens in which PNDs are located at regular intervals and separated by extended mucin spacers. In this article we show by two-dimensional NMR spectroscopy that the multivalent antigens preserve the PNDs in their native structure. We also demonstrate by ELISA that the antigens correctly present the PNDs for binding to monoclonal antibodies or polyclonal antisera from HIV-infected patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7816840      PMCID: PMC42869          DOI: 10.1073/pnas.92.1.315

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Loss of a neutralizing epitope by a spontaneous point mutation in the V3 loop of HIV-1 isolated from an infected laboratory worker.

Authors:  F di Marzo Veronese; M S Reitz; G Gupta; M Robert-Guroff; C Boyer-Thompson; A Louie; R C Gallo; P Lusso
Journal:  J Biol Chem       Date:  1993-12-05       Impact factor: 5.157

2.  Structure of a bent DNA: two-dimensional NMR studies on d(GAAAATTTTC)2.

Authors:  M H Sarma; G Gupta; R H Sarma
Journal:  Biochemistry       Date:  1988-05-03       Impact factor: 3.162

3.  Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells.

Authors:  K R Jerome; D L Barnd; K M Bendt; C M Boyer; J Taylor-Papadimitriou; I F McKenzie; R C Bast; O J Finn
Journal:  Cancer Res       Date:  1991-06-01       Impact factor: 12.701

4.  Biophysical characterization of one-, two-, and three-tandem repeats of human mucin (muc-1) protein core.

Authors:  J D Fontenot; N Tjandra; D Bu; C Ho; R C Montelaro; O J Finn
Journal:  Cancer Res       Date:  1993-11-15       Impact factor: 12.701

5.  NMR-derived solution conformations of a hybrid synthetic peptide containing multiple epitopes of envelope protein gp120 from the RF strain of human immunodeficiency virus.

Authors:  R de Lorimier; M A Moody; B F Haynes; L D Spicer
Journal:  Biochemistry       Date:  1994-03-01       Impact factor: 3.162

6.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.

Authors:  A G Dalgleish; P C Beverley; P R Clapham; D H Crawford; M F Greaves; R A Weiss
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

7.  Solution structure of the V3 loop of a Thailand HIV isolate.

Authors:  G Gupta; G M Anantharamaiah; D R Scott; J H Eldridge; G Myers
Journal:  J Biomol Struct Dyn       Date:  1993-10

8.  Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.

Authors:  J R Rusche; K Javaherian; C McDanal; J Petro; D L Lynn; R Grimaila; A Langlois; R C Gallo; L O Arthur; P J Fischinger
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

Review 9.  Mucins: structure, function, and associations with malignancy.

Authors:  P L Devine; I F McKenzie
Journal:  Bioessays       Date:  1992-09       Impact factor: 4.345

10.  A 113-amino acid fragment of CD4 produced in Escherichia coli blocks human immunodeficiency virus-induced cell fusion.

Authors:  B H Chao; D S Costopoulos; T Curiel; J M Bertonis; P Chisholm; C Williams; R T Schooley; J J Rosa; R A Fisher; J M Maraganore
Journal:  J Biol Chem       Date:  1989-04-05       Impact factor: 5.157

View more
  6 in total

1.  Determination of essential amino acids involved in the CD4-independent tropism of the X4 human immunodeficiency virus type 1 m7NDK isolate: role of potential N glycosylations in the C2 and V3 regions of gp120.

Authors:  J Dumonceaux; C Goujon; V Joliot; P Briand; U Hazan
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  An optimally constrained V3 peptide is a better immunogen than its linear homolog or HIV-1 gp120.

Authors:  Adi Moseri; Subramanyam Tantry; Yael Sagi; Boris Arshava; Fred Naider; Jacob Anglister
Journal:  Virology       Date:  2010-03-26       Impact factor: 3.616

3.  Crystal structures of human immunodeficiency virus type 1 (HIV-1) neutralizing antibody 2219 in complex with three different V3 peptides reveal a new binding mode for HIV-1 cross-reactivity.

Authors:  Robyn L Stanfield; Miroslaw K Gorny; Susan Zolla-Pazner; Ian A Wilson
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  Mimicking the structure of the V3 epitope bound to HIV-1 neutralizing antibodies.

Authors:  Amit Mor; Eugenia Segal; Brenda Mester; Boris Arshava; Osnat Rosen; Fa-Xiang Ding; Joseph Russo; Amnon Dafni; Fabian Schvartzman; Tali Scherf; Fred Naider; Jacob Anglister
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162

5.  Proline-rich tandem repeats of antibody complementarity-determining regions bind and neutralize human immunodeficiency virus type 1 particles.

Authors:  J D Fontenot; V R Zacharopoulos; D M Phillips
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

6.  Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades.

Authors:  Miroslaw K Gorny; Constance Williams; Barbara Volsky; Kathy Revesz; Sandra Cohen; Victoria R Polonis; William J Honnen; Samuel C Kayman; Chavdar Krachmarov; Abraham Pinter; Susan Zolla-Pazner
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.